These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 32654398)
1. Role of O-linked N-acetylglucosamine in the homeostasis of metabolic organs, and its potential links with diabetes and its complications. Morino K; Maegawa H J Diabetes Investig; 2021 Feb; 12(2):130-136. PubMed ID: 32654398 [TBL] [Abstract][Full Text] [Related]
2. New insights: A role for O-GlcNAcylation in diabetic complications. Peterson SB; Hart GW Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492 [TBL] [Abstract][Full Text] [Related]
3. Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein Chen Y; Zhao X; Wu H Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):1911-1924. PubMed ID: 31462094 [TBL] [Abstract][Full Text] [Related]
4. O-GlcNAcylation, a sweet link to the pathology of diseases. Nie H; Yi W J Zhejiang Univ Sci B; 2019 May; 20(5):437-448. PubMed ID: 31090269 [TBL] [Abstract][Full Text] [Related]
5. Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications. Qin CX; Sleaby R; Davidoff AJ; Bell JR; De Blasio MJ; Delbridge LM; Chatham JC; Ritchie RH Pharmacol Res; 2017 Feb; 116():45-56. PubMed ID: 27988387 [TBL] [Abstract][Full Text] [Related]
6. Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications. Chatham JC; Young ME; Zhang J Curr Opin Pharmacol; 2021 Apr; 57():1-12. PubMed ID: 32937226 [TBL] [Abstract][Full Text] [Related]
7. Protein O-GlcNAcylation in diabetes and diabetic complications. Ma J; Hart GW Expert Rev Proteomics; 2013 Aug; 10(4):365-80. PubMed ID: 23992419 [TBL] [Abstract][Full Text] [Related]
8. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. Akimoto Y; Hart GW; Wells L; Vosseller K; Yamamoto K; Munetomo E; Ohara-Imaizumi M; Nishiwaki C; Nagamatsu S; Hirano H; Kawakami H Glycobiology; 2007 Feb; 17(2):127-40. PubMed ID: 17095531 [TBL] [Abstract][Full Text] [Related]
9. Elevated O-GlcNAcylation stabilizes FOXM1 by its reduced degradation through GSK-3β inactivation in a human gastric carcinoma cell line, MKN45 cells. Inoue Y; Moriwaki K; Ueda Y; Takeuchi T; Higuchi K; Asahi M Biochem Biophys Res Commun; 2018 Jan; 495(2):1681-1687. PubMed ID: 29196265 [TBL] [Abstract][Full Text] [Related]
10. Feedback Regulation of Lin CH; Liao CC; Chen MY; Chou TY Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653 [TBL] [Abstract][Full Text] [Related]
11. Regulation of protein O-GlcNAcylation by circadian, metabolic, and cellular signals. Liu X; Cai YD; Chiu JC J Biol Chem; 2024 Feb; 300(2):105616. PubMed ID: 38159854 [TBL] [Abstract][Full Text] [Related]
12. Excess Protein O-GlcNAcylation Links Metabolic Derangements to Right Ventricular Dysfunction in Pulmonary Arterial Hypertension. Prisco SZ; Rose L; Potus F; Tian L; Wu D; Hartweck L; Al-Qazazi R; Neuber-Hess M; Eklund M; Hsu S; Thenappan T; Archer SL; Prins KW Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019763 [TBL] [Abstract][Full Text] [Related]
14. Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in mice. Ida S; Morino K; Sekine O; Ohashi N; Kume S; Chano T; Iwasaki K; Harada N; Inagaki N; Ugi S; Maegawa H Diabetologia; 2017 Sep; 60(9):1761-1769. PubMed ID: 28642969 [TBL] [Abstract][Full Text] [Related]
15. Emerging Role of Protein O-GlcNAcylation in Liver Metabolism: Implications for Diabetes and NAFLD. Xie Z; Xie T; Liu J; Zhang Q; Xiao X Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768465 [TBL] [Abstract][Full Text] [Related]
16. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells. de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of Xu H; Du M; Shen Y; Yang Y; Ding F; Yu S Molecules; 2021 Sep; 26(19):. PubMed ID: 34641427 [No Abstract] [Full Text] [Related]
18. The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy. Semba RD; Huang H; Lutty GA; Van Eyk JE; Hart GW Proteomics Clin Appl; 2014 Apr; 8(3-4):218-31. PubMed ID: 24550151 [TBL] [Abstract][Full Text] [Related]
19. Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy. Gurel Z; Sieg KM; Shallow KD; Sorenson CM; Sheibani N Mol Vis; 2013; 19():1047-59. PubMed ID: 23734074 [TBL] [Abstract][Full Text] [Related]
20. Exploring leukocyte O-GlcNAcylation as a novel diagnostic tool for the earlier detection of type 2 diabetes mellitus. Springhorn C; Matsha TE; Erasmus RT; Essop MF J Clin Endocrinol Metab; 2012 Dec; 97(12):4640-9. PubMed ID: 23066116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]